ProQR Therapeutics
PRQR
#8914
Rank
HK$1.13 B
Marketcap
HK$10.73
Share price
-8.67%
Change (1 day)
-1.46%
Change (1 year)

Revenue for ProQR Therapeutics (PRQR)

Revenue in 2025 (TTM): HK$0.13 Billion

According to ProQR Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$0.13 Billion. In 2024 the company made a revenue of HK$0.15 Billion an increase over the revenue in the year 2023 that were of HK$55.5 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ProQR Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$0.13 B-14.82%
2024 HK$0.15 B184.38%
2023 HK$55.5 M81.99%
2022 HK$30.5 M149.45%
2021 HK$12.22 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Atara Biotherapeutics
ATRA
HK$1.19 B 780.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.83 B 519.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Actinium Pharmaceuticals
ATNM
HK$0.7 M-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA